Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 2, 2013, Pages 766-774

  Wang, Huanyu ^a,b   Schwaderer, Andrew L ^a,b   Kline, Jennifer ^a,b   Spencer, John David ^a,b   Kline, David ^b   Hainsa, David S ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEASE; RIBONUCLEASE 7; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEUS MIRABILIS; STAPHYLOCOCCUS SAPROPHYTICUS;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; GENE EXPRESSION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROBIAL SENSITIVITY TESTS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; PROTEUS MIRABILIS; RECOMBINANT PROTEINS; RIBONUCLEASES; STAPHYLOCOCCUS SAPROPHYTICUS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84872854029     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01378-12     Document Type: Article

References (17)

1. Almeida PF, Pokorny A. 2009. Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: From kinetics to thermodynamics. Biochemistry 48:8083-8093.
2. Rathinakumar R, Walkenhorst WF, Wimley WC. 2009. Broad-spectrum antimicrobial peptides by rational combinatorial design and highthroughput screening: The importance of interfacial activity. J. Am. Chem. Soc. 131:7609-7617.
3. Wimley WC, Hristova K. 2011. Antimicrobial peptides: Successes, challenges and unanswered questions. J. Membr. Biol. 239:27-34.
4. Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
5. Jiang Z, Vasil AI, Hale JD, Hancock RE, Vasil ML, Hodges RS. 2008. Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers 90:369-383.
6. Harder J, Schroder JM. 2002. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277:46779-46784.
7. Torrent M, Badia M, Moussaoui M, Sanchez D, Nogues MV, Boix E. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall. FEBS J. 277:1713-1725.
8. Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, Chang MD, Chen C, Wu SH, Liao YD. 2007. The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J. Biol. Chem. 282:4626-4633.
9. Spencer JD, Schwaderer AL, Dirosario JD, McHugh KM, McGillivary G, Justice SS, Carpenter AR, Baker PB, Harder J, Hains DS. 2011. Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int. 80:174-180.
10. Ahn HS, Cho W, Kang SH, Ko SS, Park MS, Cho H, Lee KH. 2006. Design and synthesis of novel antimicrobial peptides on the basis of alpha helical domain of Tenecin 1, an insect defensin protein, and structureactivity relationship study. Peptides 27:640-648.
11. Soliman W, Wang L, Bhattacharjee S, Kaur K. 2011. Structure-activity relationships of an antimicrobial peptide plantaricins from two-peptide class IIb bacteriocins. J. Med. Chem. 54:2399-2408.
12. Hovelius B, Mardh PA. 1984. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev. Infect. Dis. 6:328-337.
13. Koten B, Simanski M, Glaser R, Podschun R, Schroder JM, Harder J. 2009. RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PLoS One 4:e6424. doi:10.1371/journal.pone.0006424.
14. Thomas S, Karnik S, Barai RS, Jayaraman VK, Idicula-Thomas S. 2010. CAMP: A useful resource for research on antimicrobial peptides. Nucleic Acids Res. 38:D774-D780.
15. Rice P, Longden I, Bleasby A. 2000. EMBOSS: The European molecular biology open software suite. Trends Genet. 16:276-277.
16. Biyikli NK, Alpay H, Guran T. 2005. Hypercalciuria and recurrent urinary tract infections: Incidence and symptoms in children over 5 years of age. Pediatr. Nephrol. 20:1435-1438.
17. Brogden KA. 2005. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.